These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 29087206)
41. Response to treatment in bipolar disorder. Cruceanu C; Alda M; Rouleau G; Turecki G Curr Opin Psychiatry; 2011 Jan; 24(1):24-8. PubMed ID: 21088584 [TBL] [Abstract][Full Text] [Related]
42. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium. Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431 [TBL] [Abstract][Full Text] [Related]
43. Is monotherapy as good as polypharmacy in long-term treatment of bipolar disorder? Alda M; Yatham LN Can J Psychiatry; 2009 Nov; 54(11):719-25. PubMed ID: 19961659 [No Abstract] [Full Text] [Related]
44. [Recurrence following discontinuation of 28 years of lithium therapy]. Wegmann SD; Kessing LV Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017 [TBL] [Abstract][Full Text] [Related]
45. Chronic lithium treatment increased intracellular S100ß levels in rat primary neuronal culture. Emamghoreishi M; Keshavarz M; Nekooeian AA Acta Med Iran; 2015; 53(2):89-96. PubMed ID: 25725177 [TBL] [Abstract][Full Text] [Related]
46. Lithium might be associated with better decision-making performance in euthymic bipolar patients. Adida M; Jollant F; Clark L; Guillaume S; Goodwin GM; Azorin JM; Courtet P Eur Neuropsychopharmacol; 2015 Jun; 25(6):788-97. PubMed ID: 25840740 [TBL] [Abstract][Full Text] [Related]
47. Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations. Girardi P; Brugnoli R; Manfredi G; Sani G Drugs R D; 2016 Dec; 16(4):293-302. PubMed ID: 27770296 [TBL] [Abstract][Full Text] [Related]
48. Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania. Dandash O; Yücel M; Daglas R; Pantelis C; McGorry P; Berk M; Fornito A Transl Psychiatry; 2018 Mar; 8(1):59. PubMed ID: 29507281 [TBL] [Abstract][Full Text] [Related]
49. Self-reported medication adherence and its correlates in a lithium-maintained cohort with bipolar disorder at a tertiary care centre in India. Singh S; Kumar S; Mahal P; Vishwakarma A; Deep R Asian J Psychiatr; 2019 Dec; 46():34-40. PubMed ID: 31590007 [TBL] [Abstract][Full Text] [Related]
50. [Mood stabilizers--past, present and future]. Sümegi A Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018 [TBL] [Abstract][Full Text] [Related]
52. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835 [TBL] [Abstract][Full Text] [Related]